![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ng2107contents.gif)
Acta Cryst. (2006). E62, m2816-m2817 [ doi:10.1107/S1600536806039663 ]
-1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,8-naphthyridine-3-carboxylato)cadmium(II)] trihydrate]Abstract: In the title compound, {[Cd(C15H16FN4O3)2]·3H2O}n, the CdII atom exists in a distorted octahedral geometry that is defined by two N atoms and four carboxylate O atoms from the 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,8-naphthyridine-3-carboxylato monoanions. The structure is a 13.92 × 14.17 Å parallelogram grid. The Cd atom lies on a center of inversion.
Online 4 October 2006
Copyright © International Union of Crystallography
IUCr Webmaster